Journal of vitreoretinal diseases · 2026
Correlation of Hydroxychloroquine Whole Blood Levels With Real and Ideal Body Weight Dosing and Development of Retinal Toxicity.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kaiser Alexis, Colcombe Joseph, Cobbs Lucy, Gutowski Emily, Buyon Jill, Belmont Howard, Izmirly Peter, Saxena Amit, Modi Yasha
Аннотация
PURPOSE: To examine the correlation between hydroxychloroquine levels with real body weight and ideal body weight dose and identify patient characteristics at risk for subtherapeutic or supratherapeutic dosing.
METHODS: A retrospective chart review of 181 patients with lupus (429 unique hydroxychloroquine whole blood levels) was performed. Hydroxychloroquine levels <100 (indicating medication noncompliance) were excluded (n = 26). Summary statistics, linear regression of hydroxychloroquine level and real body weight/ideal body weight, and odds ratios (ORs) for factors associated with supratherapeutic (>2000 ng/mL) or subtherapeutic (<750 ng/mL) hydroxychloroquine levels were calculated.
RESULTS: The correlation of real body weight and hydroxychloroquine level was r = 0.124. Ideal body weight and hydroxychloroquine level had a correlation of r = 0.324. The OR of body mass index (BMI) >30 kg/m2 and supratherapeutic hydroxychloroquine level was 4.95 (95% CI, 1.98-12.39). The OR of BMI <20 kg/m2 and subtherapeutic hydroxychloroquine level was 2.90 (95% CI, 1.58-5.37). Three of 71 patients screened for toxicity had hydroxychloroquine maculopathy. These subjects had mean hydroxychloroquine levels of 1314 ng/mL (range, 1101-1553 ng/mL), 2402 ng/mL (range, 1754-3050 ng/mL), and 1223.8 ng/mL, and BMIs of 20.8 kg/m2, 29.7 kg/m2, and 19.8 kg/m2, respectively.
CONCLUSIONS: All dosing schedules show variability in hydroxychloroquine levels. Ideal body weight may correlate more strongly with hydroxychloroquine level than real body weight. Under real body weight-based guidelines, obesity may increase the risk for supratherapeutic hydroxychloroquine levels, and low weight may increase the risk for subtherapeutic levels.
METHODS: A retrospective chart review of 181 patients with lupus (429 unique hydroxychloroquine whole blood levels) was performed. Hydroxychloroquine levels <100 (indicating medication noncompliance) were excluded (n = 26). Summary statistics, linear regression of hydroxychloroquine level and real body weight/ideal body weight, and odds ratios (ORs) for factors associated with supratherapeutic (>2000 ng/mL) or subtherapeutic (<750 ng/mL) hydroxychloroquine levels were calculated.
RESULTS: The correlation of real body weight and hydroxychloroquine level was r = 0.124. Ideal body weight and hydroxychloroquine level had a correlation of r = 0.324. The OR of body mass index (BMI) >30 kg/m2 and supratherapeutic hydroxychloroquine level was 4.95 (95% CI, 1.98-12.39). The OR of BMI <20 kg/m2 and subtherapeutic hydroxychloroquine level was 2.90 (95% CI, 1.58-5.37). Three of 71 patients screened for toxicity had hydroxychloroquine maculopathy. These subjects had mean hydroxychloroquine levels of 1314 ng/mL (range, 1101-1553 ng/mL), 2402 ng/mL (range, 1754-3050 ng/mL), and 1223.8 ng/mL, and BMIs of 20.8 kg/m2, 29.7 kg/m2, and 19.8 kg/m2, respectively.
CONCLUSIONS: All dosing schedules show variability in hydroxychloroquine levels. Ideal body weight may correlate more strongly with hydroxychloroquine level than real body weight. Under real body weight-based guidelines, obesity may increase the risk for supratherapeutic hydroxychloroquine levels, and low weight may increase the risk for subtherapeutic levels.